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allow MHC class II molecules to present antigenic epi-David L. Woodland,*² and Dario A. A. Vignali*²³
*Department of Immunology topes as large nested sets of peptides of variable length
(10±35 amino acids) (Rudensky et al., 1991; Chicz et al.,St. Jude Children's Research Hospital
Memphis, Tennessee 38101 1992, 1993; Hunt et al., 1992). Structural studies of MHC
class II:peptide complexes have shown that on either²Department of Pathology
University of Tennessee Medical Center side of the minimal MHC-binding epitope there can be
at least two peptide flanking residues (PFRs) that areMemphis, Tennessee 38163
within the MHC groove and thus potentially accessible
to the T cell receptor (TCR) (Stern et al., 1994; Fremont
et al., 1996).Summary
The H-2Ak±restricted immunodominant epitope of hen
egg white lysozyme (HEL), 52±61, has been used exten-Naturally processed MHC class II±bound peptides
sively to study TCR recognition (Allen et al., 1984, 1985).possess ragged NH2 and COOH termini. It is not known
The putative MHC anchor residues for this epitope havewhether these peptide flanking residues (PFRs), which
been assigned by functional and binding studies as D52lie outside the MHC anchor residues, are recognized
and to a lesser extent I58 and R61, thus defining theby the TCR or influence immunogenicity. Here we ana-
minimal epitope as 52±61 (Figure 1) (Allen et al., 1987;lyzed T cell responses to the COOH-terminal PFR of
Nelson et al., 1996). All T cells specific for this peptidethe H-2Ak immunodominant epitope of hen egg lyso-
are dependent on L56, since this is the only residuezyme (HEL) 52±61. Surprisingly, the majority of T cells
in this sequence that differs between HEL and mousewere completely dependent on, and specific for, the
lysozyme (ML) (Allen et al., 1987). This amino acid hasCOOH-terminal PFR of the immunogen. In addition,
therefore been defined as the primary TCR contact resi-there were striking correlations between TCR Vb us-
due. Some TCRs require the conserved residues Y53age and PFR dependence. We hypothesize that the
and/or Q57 for effective recognition. However, T cellVa CDR1 region recognizes NH2-terminal PFRs, while
dependence on these residues is variable, and so theythe Vb CDR1 region recognizes COOH-terminal PFRs.
are referred to as secondary contact residues. Of theLast, peptides containing PFRs were considerably
four PFRs (S50, T51, W62, and W63), W62 is the onlymore immunogenic and mediated a greater recall re-
residue that differs between HEL and ML (Figure 1).sponse to the HEL protein. These results demonstrate
Our previous studies have shown that certain murinethat PFRs, which are a unique characteristic of pep-
T cell hybridomas, which lack CD4, require the COOH-tides bound to MHC class II molecules, can have a
terminal PFR W62:W63 for recognition (Vignali andprofound effect on TCR recognition and T cell function.
Strominger, 1994a, 1994b). Although peptides lackingThese data may have important implications for pep-
these residues failed to stimulate interleukin-2 (IL-2) se-tide-based immunotherapy and vaccine development.
cretion, they did induce partial CD3z tyrosine phosphor-
ylation, reminiscent of observations made with T cellIntroduction
clones anergized by altered peptide ligands (Sloan-Lan-
caster et al., 1994; Madrenas et al., 1995). Furthermore,T cells can recognize antigenic peptides only in the
the WW PFRs did not affect the affinity of HEL 48±61context of major histocompatibility complex (MHC) class
for H-2Ak or MHC stability, as determined by floppyI or class II molecules (reviewed by Townsend and
Bodmer, 1989; Chien and Davis, 1993). Significant prog- versus compact dimer formation, suggesting that they
ress has been made in the elucidation of MHC structure do not influence MHC structure (Nelson et al., 1993,
and the characterization of MHC-bound peptides (re- 1994; Vignali and Strominger, 1994b). The analysis of
viewed by Rotzschke and Falk, 1992; Stern and Wiley, naturally processed, H-2Ak-eluted peptides from HEL-
1994). MHC class I molecules require peptides for cor- pulsed B cells has shown that peptides can be gener-
rect folding, and they form conserved interactions with ated both with and without these tryptophan residues
the NH2- and COOH-terminal ends of the peptide (Town- (Nelson et al., 1992; Vignali et al., 1993).
send et al., 1990; Fremont et al., 1992; Latron et al., In the present study, we asked whether the TCR can
1992; Madden et al.,1992, 1993; Matsumura et al., 1992). directly recognize PFRs and examined the consequence
This intrinsic requirement is evident from both structural of this interaction on peptide immunogenicity, T cell
and peptide elution studies and places strict constraints function, and repertoire selection.
on peptide length (8±10 amino acids for the majority of
peptides).
In contrast, MHC class II molecules are not dependent Results
on peptides for folding, and their binding groove is open
at both ends (Brown et al., 1993; Stern and Wiley, 1994; PFRs Can Act as Dominant TCR Contact Residues
T cell hybridomas were generated from HEL 48±63-
immunized B10.BR mice and were selected according³To whom correspondence and requests for reagents should be
addressed (dario.vignali@stjude.org). to their ability to respond to both the immunizing peptide
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Figure 1. The Immunodominant Epitope of HEL for H-2Ak
A model of the HEL 48±63 peptide used in this study. The homolo-
gous murine sequence (ML) is also shown. The numbers refer to
the HEL residues; ML residue numbers are one greater than the
number shown. The dark shaded box encompasses the putative
minimal MHC binding epitope, with arrows indicating residues that
have been suggested to bind either the MHC or TCR molecules by
functional studies (Allen et al., 1987; Nelson et al., 1996). While there
is strong evidence for R52 binding to the NH2-terminal, P1 pocket
of H-2Ak molecules, it is unclear whether S60 or R61 binds to the
COOH-terminal, P9/P10 pocket. The large arrow above L56 high-
lights the immunodominant residue for the peptide. The open boxes
highlight the PFRs that we predict would be within the MHC groove
by extrapolation from current MHC class II:peptide complexes (Stern
et al., 1994; Fremont et al., 1996).
and the native HEL protein (data not shown). All 34 hy-
bridomas failed to produce IL-2 in response to the pep-
tide analog HEL 48-L56A-63 (data not shown). This find-
ing is consistent with previous studies demonstrating
that L56 is a primary TCR contact residue for this epitope
(Allen et al., 1987). Surprisingly, two thirds of this panel
(65%; 22 of 34) were also highly dependent on the PFR Figure 2. Characterization of PFR-Dependent T Cell Hybridomas
W62:W63, while the remaining third were completely T cell hybridomas generated from (A) HEL 48±63±immunized or (B)
independent of these residues. For instance, the WW- 48±61KK±immunized mice have a WW or KK prefix, respectively.
The data represent IL-2 production in response to the peptidesindependent hybridomas WW148 and WW161 responded
indicated in an antigen presentation assay and are the means ofstrongly to HEL 48±61 (Figure 2A). In contrast, the WW-
two or three experiments. Representative hybridomas that are eitherdependent hybridomas WW241 and WW245 failed to
dependent or independent of the PFR, as determined by their re-produce any IL-2 with the highest concentration of HEL
sponse to HEL 48±61, are shown. Hybridomas were also stimulated
48±61, even though they responded to low concentra- with APCs expressing H-2Ak molecules with CAP transfectants. Data
tions of HEL 48±63 (Figure 2A). Because the WW PFRs here are the means of two or three experiments 6 SEM. None of
do not alter peptide affinity or MHC stability, they are the hybridomas responded to HEL.48-L56A-63.CAP transfectants
(data not shown). See Experimental Procedures for protocols. Fullunlikely to affect MHC structure (Nelson et al., 1993,
details of peptide specificity and function of all the T cell hybridomas1994; Vignali and Strominger, 1994b). It is noteworthy
described in this study are available from the authors.that the hybridomas were either completely dependent
or independent of the PFR, with none showing a partial
strongly to both the HEL.48±63.CAP and HEL.48±response to HEL 48±61.
61AA.CAP transfectants (Figure 2A; righthand bars).Previous studies have shown that a relatively low per-
Even though these transfectants possessed ligand den-centage (z1%) of MHC class II molecules are loaded
sities substantially higher than conventional peptide-with peptides derived from either exogenous antigen or
pulsed APCs, the WW-dependent hybridomas WW241synthetic peptide (Vignali et al., 1993). Thus, the inability
and WW245 still failed to respond to HEL.48±61AA.CAPof WW-dependent hybridomas to respond to HEL 48±61
while responding strongly to the HEL.48±63.CAP trans-may de due to low ligand density on the surface of the
fectants (Figure 2A). None of the hybridomas respondedantigen-presenting cell (APC). To examine this possibil-
to the HEL.48-L56A-63.CAP transfectants (data notity, we produced APCs that expresses a single, defined
shown). Thus, the WW-dependent hybridomas wereMHC:peptide complex, resulting in a substantially higher
completely unable to respond to HEL 48±61 regardlesspercentage of the MHC class II molecules loaded with
of ligand density.a defined peptide (Kozono et al., 1994). The A20.J B cell
line was transfected with constructs encoding the wild- Can any amino acid mediate the production of PFR-
dependent T cells? This questionwas initially addressedtype H-2Aka chain and the H-2Akb chain recombinantly
attached to either HEL.48±63, HEL.48±61AA, or HEL.48- by generating hybridomas from mice immunized with
a HEL 48±63 analog peptide in which the tryptophanL56A-61 (referred to here as CAP [covalently attached
peptide] transfectants). As expected, the WW-inde- residues were replaced with lysine (HEL 48±61KK). Strik-
ingly, the majority of the hybridomas (68%; 32 of 47)pendent hybridomas WW148 and WW161 responded
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We then determined which of the two PFRs were cru-
cial for TCR recognition. Nine of ten WW-dependent
hybridomas responded with equivalent sensitivities to
HEL 48±63 and the WA analog peptide, thus having an
EC5048±61WA/EC5048±63 ratio of z1 (Figure 3A). Their response
was comparable to that of the four WW-independent
hybridomas tested. However, they failed to recognize
the AW peptide, demonstrating that TCR recognition is
focused toward W62. The tenth hybridoma, WW242,
did not respond to either peptide analog and was thus
affected by substitutions at both W62 and W63. Of note,
W62 but not W63 differs between HEL and ML (Figure
1). The lack of recognition of W63 may be due either to
tolerance induction by the ML peptide or to the inacces-
sibility of the W63 residue.
In contrast, the KK-dependent hybridomas were af-
fected by substitutions at both PFRs and displayed a
more complex pattern of recognition (Figure 3B). One
third of the hybridomas (34%; 11 of 32) did not respond
to either the AK or the KA analog peptides and thus
required both residues for recognition. Another third
(34%; 11 of 32) were able to respond fully to only one
of the two analog peptides, while the remaining third
possessed a phenotype between these two extremes.
No preference was observed between the two PFRs,
since similar numbers of hybridomas responded to AK
only (6 of 11) and KA only (5 of 11). Therefore, the TCR is
equally capable of recognizing either of the two COOH-
terminal PFRs.
Taken together, these data argue against the possibil-
ity that the TCR is merely recognizing a peptide-inducedFigure 3. PFR-Dependent T Cell Hybridomas Are Highly Specific
conformational change in the MHC molecule, and in-The response of (A) WW- and (B) KK-dependent and independent
stead imply stringent requirements for the recognitionhybridomas to various PFR analog peptides. Data represent the
of PFRs.ratio of the EC50 value for the response to the analog peptide over
the immunogen and are plotted as the geometric means of three
experiments. This was done to normalize the data for differences
in the sensitivity of hybridomas to the immunogen, and thus an Recognition of PFRs Skews the T Cell Repertoire
identical response to immunogen and analog gives a ratio of 1. There is now substantial structural and functional evi-
- -, HEL 48±61. See Experimental Procedures for protocol.
dence demonstrating that complementarity-determin-
ing region 3 (CDR3) of the TCR, encoded by the V(D)J
junction, interacts with the central peptide residues (Jor-
were totally dependent on the lysine PFR. For instance, gensen et al., 1992; Garbozi et al., 1996; Garcia et al.,
while the KK-independent hybridomas KK11C2 and 1996). Furthermore, recent studies have shown that
KK6C6 responded strongly to HEL 48±61, the KK-depen- CDR1 and CDR2, which are encoded within the V re-
dent hybridomas KK5C1 and KK6C3 failed to produce gions, can also recognize peptide residues in addition
any IL-2 with the highest concentration of HEL 48±61 to the surrounding MHC molecule (Sant'Angelo et al.,
(Figure 2B). Again, these hybridomas were unable to 1996). We reasoned that PFRs, which are at the extrem-
respond to the HEL.48±61AA.CAP transfectants. In sum- ity of the MHC groove, would be recognized by the TCR
mary, these data demonstrate the profound PFR depen- V region and thus result in skewed TCR usage.
dence of the majority of hybridomas derived from HEL To test this notion, we first determined TCR Va and
48±63 or HEL 48±61KK immunized mice. Furthermore, Vb gene usage by flow cytometry, polymerase chain
these data suggest that PFRs can act as dominant TCR reaction (PCR), and DNA sequencing. Analysis of the
contact residues. TCRa VJ junctional sequence showed that only 3 of
29 WW-dependent and WW-independent hybridomas
analyzed were identical (Table 1 and data not shown).Recognition of C-Terminal PFRs Is Highly Specific
Using a panel of peptide analogs, we found that most Preferential usage of Va4 and Va11 was observed with
both the WW-dependent and WW-independent hybrido-of the hybridomas were highly specific for the PFRs of
their respective immunogen (Figure 3). Only two WW- mas. (Figure 4A). However, no obvious correlation was
noted between PFR dependence and Va gene usage.dependent and two KK-dependent hybridomas of the 28
tested (86%) responded to analog peptides containing In contrast, a dramatic segregation of TCR Vb gene
usage was observed (Figure 4B). A substantial propor-amino acid substitutions of the PFR. This demonstrates
that these hybridomas are highly specific for their re- tion of the WW-dependent hybridomas (80%; 18 of 22)
were either Vb8.31 (7) or Vb141 (11), while two thirds ofspective PFRs.
Immunity
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Table 1. TCR Sequence Analysis of HEL 48±63 and 48±61KK±Specific Hybridomas
TCR Va Junctional Sequence
Hybridoma TCR Va V N J TCR Ja TCR Vb
WW-independent hybridomas
WW149 11.3 CAAE A NMGYKLTF 9 16
WW161 11.3 CAA YY NTNTGKLTF 27 16
WW145 1.5 CA G TNTGKLTF 27 8.2
WW195 3.2 CAV G GYKLTF 9 16
WW148 11.2* CAA DG GSSGNKLIF 32 4
WW211 4.1 CAL GDST GSFNKLTF 4 16
WW156 10.3 CAM DS DYSNNRLTL 7 14
WW170 11.3 CAAE A NSNYQLIF 33 8.3
WW138 11.1/6* CAAE A NSGTYQRF 13 3
WW-dependent hybridomas
WW245 3.2 CALS AS NYAQGLTF 26 8.3
WW241² 8³ CALS ES SNYQLIR 33 8.3
16.1 CAPG MG NNRIFF 31
WW236 8³ CALS DP SGSWQLIF 22 8.3
WW174 11.4* CAAE L NYAQGLTF 26 14
WW134 11.4* CAAE G NYAQGLTF 26 14
WW221 4.13§ CAL Y TEGADRLTF 45 8.3
WW158 1.7 CAA SGG NAYKVIF 30 8.2
WW157 4.3/4 CALG D NYNQGKLIF 23 14
WW152 11.3 CAAE AG YAQGLTF 26 14
WW136 4.3/4 CALG DA SGGNYKPTF 6 16
WW153 18.2 CAT EG NYAQGLTF 26 14
WW133 11.3 CAAE A NYAQGLTF 26 14
WW151 3.2 CALS NMGYKLTF 9 14
WW181 4.3/4 CALG EA GNTGKLIF 37 8.2
WW142 11.3 CAAE A NYAQGLTF 26 14
WW204 11.3 CAA VN NYAQGLTF 26 14
WW129 4.13§ CALG M NYNQGKLIF 23 8.3
KK-dependent hybridomas
KK7B7 16 CAPG MG NNRIFF 31 8.3
KK7H5 8.2/5/14 CALS HI TGNTGKLIF 37 14
KK6D9 1.5 CAVS M SNYNVLYF 21 8.3
KK8E12 4.3/4 CAL VFY DTNAYKVIF 30 14
KK5E7 1.5 CAVS IG TGNYKYVF 40 14
KK12B8 4.3/4 CALG DP GTQVVGQLTF 5 8.3
TCR usage determined by flow cytometry, reverse transcription±PCR, and DNA sequencing as described in Experimental Procedures. Hybrido-
mas are grouped according to their PFR dependency and specificity. Each group is ordered according to their sensitivity to the immunogen
(in descending order). Three WW-dependent and two KK-dependent hybridomas that were found to be identical to those listed are not shown.
WW142 and WW133 have identical amino acid sequences but distinct DNA sequences.
*Va11.2 and Va11.1/6 defined by recognition by RR8.1 (Va11.1, 11.2b,d), which appears not to recognize Va11.4.
²WW241 has two in-frame TCRa chains; this hybridoma is KT651KT502 (each antibody recognizes a subset of Va8 TCR); the expression of
Va16.1 is unknown.
³Subfamily member is either 8.6, 8.8, 8.12, or 8.13.
§Unique amino acid and DNA sequence distinct from other Va4 family members with Y89F, thus designated Va4.13.
the WW-independent hybridomas (66%; 8 of 12) were data suggest that the TCR Vb domain may lie over the
COOH terminus of the peptide.either Vb8.21 (4) or Vb161 (4). Further analysis of TCR
Va and Vb usage revealed preferential usage of Ja26 Finally, we asked whether the HEL 48±61KK±specific
hybridomas also exhibit a similar segregation of TCRwith Va11 but only when paired with Vb14 (Table 1).
Ja26 may be required either to allow efficient pairing usage. There clearly was a preferential usage of certain
Vb elements among KK-dependent versus KK-indepen-between Va11 and Vb14 or to facilitate appropriate posi-
tioning of Vb14 for recognition of the WW PFR. Taken dent hybridomas (Figure 4D). Among the KK-indepen-
dent hybridomas, most expressed either Vb1, Vb8.1, ortogether, these data reveal a strong correlation between
PFR dependence and TCR Vb, but not Va, usage. Vb8.2 (87%; 13 of 15). In contrast, all of the Vb61 (7),
Vb8.31 (6), Vb131 (3), and Vb141 (5) hybridomas wereNext, we asked whether the secondary TCR contact
residues, Y53 and Q57, could influence TCR usage and KK dependent (66%; 21 of 32). Why do both WW- and
KK-dependent hybridomas use Vb8.3 and Vb14? Therethus provide further evidence for the orientation of the
TCR:MHC class II interaction. The only correlation found are three possible explanations. First, these residues
are recognized by TCR Va. However, no correlationswas between dependence on Q57 and TCR Vb usage
(Figure 4C). Within the WW-dependent hybridomas, were observed between Va usage and PFR depen-
dence, and the Vb8.31 and Vb141, KK-dependent hy-Vb141 T cells were independent of Q57, while most of
the Vb8.31 cells were dependent. Taken together, these bridomas all used distinct Va chains (Table 1 and Figure
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Figure 4. Correlation between Recognition
of PFRs and TCR Vb Usage
T cells hybridomas are plotted according to
their response to the peptides indicated and
are depicted by symbols representing spe-
cific TCR Va or Vb elements. The latter was
determined by reverse transcription PCR, se-
quencing, and flow cytometry. (A) Va and (B)
Vb usage by hybridomas generated from HEL
48±63±immunized mice. (C) The response of
WW-dependent hybridomas to alanine sub-
stitutions of Y53 and Q57 is depicted as the
ratio of the EC50 value for the response to the
analog peptide over HEL 48±63. The symbols
represent TCR Vb usage. (D) Vb usage by
hybridomas generated from HEL 48±61KK±
immunized mice.
The diagonal solid lines indicate where the
EC50 values in response to peptides on the
x- and y-axes are identical (i.e., the addition
of PFRs neither increases nor decreases the
response to HEL 48±61). The dashed lines are
1 log10 to either side of the solid line. Hybrido-
mas within the dashed lines are considered
PFR independent. See Experimental Proce-
dures for protocol.
3). Second, TCR Va may alter the position of TCR Vb, cells among the CD41 T cell population following restim-
ulation with either the immunogen or HEL 48±61. Sub-thus allowing for specific recognition of either the WW
or KK PFR. Third, different residues in CDR1b recognize stantially higher percentages of T cells from HEL 48±63±,
48±61KK±, and 48±61EE±immunized mice (43%, 58%,the WW and KK PFRs. In summary, these data show
that different PFRs mediate the selection of T cells ex- and 45%, respectively) were reactivated (CD251) in re-
sponse to their respective immunogens than T cells frompressing distinct TCR Vb elements, supporting the no-
tion that the TCR directly recognizes PFRs. HEL 48±61-immunized mice (29%) (Figure 5B). Further-
more, only 16%±26% of the T cells from HEL 48±63±,
48±61KK±, and 48±61EE±immunized mice could be re-PFRs Potentiate T Cell Responses
Given the high percentage of T cell hybridomas that activated with HEL 48±61. Similar results were obtained
when CD69 expression was used as a measure of reacti-were dependent on PFRs, we reasoned that peptides
possessing such residues might be more immunogenic. vation (data not shown). These data confirm the hybrid-
oma data and suggest that more than half of the T cellsTo test this possibility, B10.BR mice were immunized
with either HEL protein, HEL 48±63, or HEL 48±61, and generated were dependent on PFRs (dependent on WW,
41%; KK, 54%; and EE, 63%). Formal frequency analysislymph node T cells were tested for their ability toprolifer-
ate in response to all three immunogens (Figure 5A). will need to be performed to establish whether PFRs
increase the size of the available precursor population.Three important observations were made. First, HEL
48±63 was as potent an immunogen as the HEL protein. The T cell response to HEL 48±61 is focused on L56,
since this is the only central peptide residue that differsHowever, T cells from mice immunized with HEL 48±61
responded poorly to their immunogen. Second, mice between ML and HEL and is thus referred to as the
immunodominant residue (Figure 1). Because leucineimmunized with HEL or HEL 48±63 generated a much
stronger recall response to 48±63 versus 48±61, while residues form relatively weak hydrophobic interactions,
we questioned whether weak interactions with centralthe response to the two peptides was identical in HEL
48±61±immunized mice. The former was also observed peptide residues promoted TCR recognition of PFRs.
To address this question, the L56 residue was substi-in C3H.HeJ mice (data not shown). Third, the recall re-
sponse to HEL protein with T cells from HEL 48±63± tuted for an arginine residue, since positively charged
amino acids are known to be favored by the TCR. Miceimmunized mice was almost as good as it was with T
cells from HEL-immunized mice. In contrast, T cells from were immunized with L56R analogs of HEL 48±63 and
48±61 (e.g., DGSTDYGIRQINSRWW rather than DGSHEL 48±61±immunized mice responded very weakly to
HEL. Taken together, these data indicate that PFRs en- TDYGILQINSRWW), and theproportion of cells that were
dependent on PFRs determined. The data show that thehance peptide immunogenicity.
We next tested whether PFRs influence the proportion L56R replacement had little influence on PFR depen-
dence: 41% of the L56-specific T cells and 38% of theof T cells generated following peptide immunization and
expansion in vitro, and/or influence their ability to be R56-specific T cells were WW dependent (Figure 5B;
righthand bars). Indeed, the presence of a positivelyreactivated. T cells from peptide immunized mice were
expanded in vitro with the immunogen and rested for charged PFR (i.e., 48±61KK vs. 48±63) had a greater
influence on the percentage of reactivated T cells than11 days. After this period, all of the cells expressed low
levels of the activation markers CD69 and CD25 (IL- similar substitutions at the immunodominant central res-
idue. Thus, HEL 48±61KK reactivated 15% more T cells2Ra). We then determined the percentage of CD251 T
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unique set of TCR Vb domains. For instance, HEL 48±63
gave rise to the strong expansion of Vb141 T cells, while
HEL 48±61KK induced a high percentage of Vb61 T cells.
HEL 48±61EE and 48±61FF favored TCR Vb domains
that could not be identified by flow cytometry (Figure
6A, bars labeled ªotherº). Of note, the absence of PFRs
in HEL 48±61 led to the preferential expansion of Vb41
T cells. While it is difficult to compare the pattern of
TCR Vb elements observed in this assay with those
expressed by the T cell hybridomas (Figure 4), the most
prominent TCR Vb elements were observed consis-
tently. Thus, WW- and KK-dependent T cells and hybrid-
omas frequently use Vb14 and Vb6, respectively. Taken
together, these data exemplify the dramatic influence
that PFRs can have on TCR usage.
Finally, we asked whether the preferential expansion
of T cells expressing particular TCR Vb domains ob-
served above correlated with functional dependence
on PFRs. If so, only a portion of these cells would be
expected to be reactivated with HEL 48±61. To test this,
an experiment similar to that shown in Figure 6A was
performed, except that the T cells were reactivated with
either the immunogen or HEL 48±61 (Figure 6B). As pre-
viously shown, only HEL 48±61KK mediated the prefer-
ential expansion of Vb61 T cells. However, the percent-
age of T cells reactivated by HEL 48±61 was comparable
Figure 5. PFRs Enhance Peptide Immunogenicity
regardless of the immunogen. Likewise, HEL 48±61
(A) Lymph node cells from B10.BR mice immunized with HEL (left
failed to reactivate a substantial proportion of the Vb141graph), HEL 48±63 (middle graph), or HEL 48±61 (right graph) were
T cells expanded by either HEL 48±63 or 48±61KK. Theserestimulated with HEL, HEL 48±63, and HEL 48±61 at the concentra-
data show that most of the T cells generated as a conse-tions indicated for 72 hr and proliferation in the last 12 hr determined
by the addition of [3H]thymidine. Data represent the means of 8 mice quence of PFRs are functionally dependent on them.
analyzed individually in three independent experiments (CPM 3
1023 6 SEM, after subtraction of background).
(B) Lymph node T cells from mice immunized with the peptide immu- Discussion
nogens indicated along the x-axis were restimulated in vitro with
the immunogen and rested for 11 days. The data represent the
Analysis of MHC class II±bound peptides has shownCD251 cells as a percentage of all of the CD41 T cells observed 24
that immunogenic epitopes are presented as large nestedhr after a secondary reactivation with the peptides indicated in the
legends. Data are presented as the means of two or three experi- sets that vary in length at the NH2 and COOH termini, a
ments 6 SEM. See Experimental Procedures for protocol. characteristic not shared by MHC class I±bound pep-
tides (Urban et al., 1993). This raises two important
questions. First, what effect do PFRs have on TCR rec-
ognition, and second, do these residues influence pep-than HEL 48±63 (58% vs. 43%), whereas HEL 48-L56R-
63 reactivated 5% fewer cells than HEL 48±63 (37% vs. tide immunogenicity and/or T cell repertoire selection
and function?43%). Taken together, these data show that PFRs can
have a significant effect on peptide immunogenicity. Previous studies have shown that NH2-terminal PFRs
can affect MHC class II stability, thus extending theWe then asked whether the skewed TCR Vb usage
observed with the hybridomascould be reproduced with lifespan of the complex and prolonging T cell stimulation
(Nelson et al., 1993, 1994). Our previous studies havebulk T cells from peptide-immunized mice. T cells from
peptide-immunized mice were restimulated and rested shown that T cell function, in the absence of CD4, could
be significantly affected by the truncation of COOH-in vitro as detailed above and in Figure 5B. CD41CD251
T cells reactivated with the immunogen were further terminal PFRs (Vignali and Strominger, 1994b). More
recently, residues flanking a measles virus fusion proteinanalyzed for TCR Vb usage using a panel of monoclonal
antibodies (see Experimental Procedures). The percent- were found to influence the responsiveness of some
human T cell clones (Muller et al., 1996). However, itage of T cells expressing each TCR Vb chain was com-
pared to the normal TCR Vb distribution in B10.BR mice was not clear what effect these residues had on MHC
class II stability, and there were inconsistencies in the(48±61 in Figure 6A, horizontal dashed lines) and to the
mean percentage of T cells reactivated with HEL 48±61 assignment of MHC binding residues when compared
with the previously published DR1 motif (Rammensee(48±61XX in Figure 6A, horizontal solid lines). As ex-
pected, significant expansion of Vb8.21 T cells over nor- et al., 1995). While all of these studies highlight the po-
tential influence of PFRs on T cell function, it is stillmal levels in B10.BR mice was observed with all of the
peptides, confirming the close association between this unclear whether the TCR can directly recognize these
residues and what the consequence of such an interac-Vb domain and HEL 48±61:H-2Ak reactivity. In contrast,
each peptide clearly expanded T cells expressing a tion might be.
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It has been suggested that MHC molecules loaded
with synthetic peptides are antigenically distinct from
those loaded with peptides derived from naturally pro-
cessed protein (Viner et al., 1996). These findings could
not account for our data, since the WW-dependent T
cell hybridomas responded strongly to native HEL. We
also tested the ability of WW- and KK-dependent hybrid-
omas to respond to HEL mutants produced in bacteria,
where the W62:W63 residues were replaced with either
lysine or alanine. The WW- and KK-dependent hybrido-
mas responded strongly to recombinant wild-type HEL
or a HEL.W62K:W63K mutant, respectively, but did not
respond to a HEL.W62A:W63A mutant (R. T. C. and
D. A. A. V., unpublished data). Taken together, these
data demonstrate that the hybridomas used in this study
could not distinguish between synthetic peptides and
the whole protein.
Could the data presented here be explained by HEL
48±61XX binding to H-2Ak with a different register than
48±61? There are several reasons why this is unlikely.
First, 48±63 and 48±61 both bind with similar affinities,
and W62 does not affect affinity or MHC stability (Nelson
et al., 1996). Second, PFR-independent T cell hybrido-
mas respond comparably to 48±63 and 48±61 (Figure
2). Third, T cells induced by 48±63 also respond to HEL.
Fourth, D52 is critical for binding to H-2Ak, and so any
shift in register is highly unlikely.
The data presented here demonstrate that PFRs have
a profound effect on T cell function and repertoire selec-
tion. The majority of T cells, tested either as hybridomas
or as T cell lines, were completely dependent on PFRs
despite their ability to respond to low concentrations of
peptide. We had previously observed such dependence
on PFRs only in the absence of CD4 (Vignali and Strom-
inger, 1994b). However, all of the T cells used in the
present study expressed CD4. Dependence on PFRs
could be due either to direct recognition by the TCR or
to alteration by the PFR of the conformation of the MHC
class II:peptide complex. Evidence in favor of a direct
interaction between the TCR and PFR comes from stud-
ies with peptide analogs and analysis of TCR Vb usage.
The data show that the majority of hybridomas depen-
dent on PFRs would not tolerate any amino acid substi-
tutions at these positions. In addition, all of the WW-
dependent hybridomas were dependent on W62 rather
than W63, while the KK-dependent hybridomas dis-
played a mosaic of preferences for either residue. The
Figure 6. Distinct Patterns of TCR Vb Usage Are Observed with
Peptides Containing Different PFRs pattern indicateVb elements that are .1 SEM above the percentage
(A) TCR Vb expression of the CD251 T cells described in Figure 5B of cells found in B10.BR mice. The solid horizontal lines in the first
was determined by flow cytometry. The peptides used for immuniza- four bar charts depict the percentages of CD251 T cells for each of
tion and in vitro restimulation are indicated in the top left corner of the TCR Vb elements observed following immunization and restimu-
each bar chart. Data are presented as the percentages of reacti- lation with HEL 48±61 (bottom bar chart). This is used to determine
vated, CD41CD251 T cells and the means of two or three experi- the effect of adding COOH-terminal PFRs on the Vb repertoire. To
ments 6 SEM for each of the Vb elements indicated. ªOtherº repre- highlight enhanced Vb usage, filled bars indicate Vb elements that
sents the percentage of cells for which antibodies are not available are .1 SEM above the horizontal line, while the cross-hatched bars
(Vb1, Vb15, Vb16, Vb18, and Vb20) and was determined by subtrac- indicate Vb elements that are greater than the horizontal line but
tion of all the Vb populations indicated from the total number of within 1 SEM.
reactivated cells. The percentage of CD41Vb51 and CD41Vb111 (B) These experiments were conducted as described above except
T cells was typically ,1% and is not shown. See Experimental that the T cells were split into two groups after resting and were
Procedures for detailed protocol. The dashed horizontal lines in the reactivated with either the immunogen (filled bars) or HEL 48±61
48±61 bar chart indicate the percentage of CD41 T cells in normal (hatched bars). Data are presented as the means of two or three
B10.BR mice expressing the TCR Vb elements indicated. This is experiments 6 SEM and are represented as the percentages of
used as a benchmark for evaluating the affect of HEL 48±61 immuni- reactivated cells as a proportion of the cells reactivated by the
zation on Vb repertoire selection. The bars filled with a diagonal immunogen. See Experimental Procedures for protocol.
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Table 2. TCR Vb CDR1 Regions
TCR-Vb CDR1
24 24a 25 26 27 28 29
Vb1 H Ð L G H N A
Vb2 K N S Q Y P W
Vb3 E Ð K G H P V
Vb4 Y Ð L G H N A
Vb5 I Ð S G H L/S S/N
Vb6 N Ð F N H D T
Vb7 D Ð M S H E T
Vb8.1 T Ð N N H D Y
Vb8.2 T Ð N N H N N
Vb8.3 T Ð N S H N Y
Vb9 T Ð M N H D T
Vb10 T Ð L G H D T
Figure 7. A Model for TCR Recognition of MHC Class II±Bound Vb11 I Ð S G H S A
Peptides and Their PFRs Vb13 I Ð S G H D T
Vb14 K G K S S P NA model of the HEL 50±63:H-2Ak complex. The TCR orientation and
Vb15 V G F Q A T SCDR3 interactions are based on the two TCR:MHC class I structures
Vb16 V Ð S N H L Y(Garbozi et al., 1996; Garcia et al., 1996). Using data presented in
Vb18 D Ð S Q V V Sthis study and elsewhere (Sant'Angelo et al., 1996), a similar mode
Vb20 E Ð K G H T Aof TCR binding to MHC class II molecules is proposed. The dashed
ovals represent the area covered by the Va CDR1 (a1), CDR2 (a2),
The TCR Vb CDR1 amino acid sequences are depicted as described
and CDR3 (a3) loops, while the solid ovals represent the area cov-
by Arden et al. (1995). Only those Vbs that are expressed in B10.BR
ered by the Vb CDR1 (b1), CDR2 (b2), and CDR3 (b3) loops. We
mice are shown.
propose that CDR1a interacts with the NH2-terminal PFR, while
CDR1b interacts with the COOH-terminal PFR.
is unlikely to be significant because of conservation of
S50:T51 between ML and HEL (Figure 1). However, weformer is presumably due to self-tolerance, since W63
is conserved between HEL and ML (Figure 1). It is diffi- see no theoretical reason why recognition of NH2-termi-
nal PFRs should not occur with other peptides. Thiscult to argue that such fine specificity could be mediated
by PFR-induced alterations in MHC structure. Last, anal- notion is supported by the work of Sant'Angelo and
colleagues (1996), who have suggested that the Va re-ysis of T cells from peptide-immunized mice showed
that different PFRs elicited distinct patterns of TCR Vb gion of an H-2Ak±restricted TCR recognizes an amino
acid in the NH2-terminal P2 position of the peptide (anal-usage. On the basis of these results, it is difficult to
argue that the TCR does not directly recognize these ogous to Y53 in the HEL 48±63 peptide; Figure 1). Taking
these findings together, we propose a generalizedresidues.
One of the most striking findings of this study was model for TCR recognition of any MHC class II:peptide
complex in which the TCR Va CDR1 loop can bind tothe influence of PFRs on TCR Vb usage. While skewed
TCR usage has been observed before, alteration of key NH2-terminal PFRs, while the TCR Vb CDR1 loop can
bind to COOH-terminal residues (Figure 7).TCR contact residues did not result in a substantial
change in TCR V usage (Jorgensen et al., 1992). How- Is there any correlationbetween PFR dependence and
the amino acid composition of the selected Vb CDR1ever, in the present study we showed that peptides
differing in PFRs elicited T cells expressing distinct TCR region? Although there does not appear to be any strik-
ing correlations comparable to those identified forVb elements. This suggests that the TCR Vb domain
directly interacts with PFRs. Recent studies have solved CDR3:peptide interactions (Jorgensen et al., 1992),
there are some intriguing parallels (Table 2). First, thethe structure of two TCR:peptide:MHC class I com-
plexes and have shown that the TCR binds to MHC only TCR Vb domain consistently selected by trypto-
phan PFR is Vb14. This is the only Vb that has a serinemolecules in a diagonal orientation, such that Va is posi-
tioned toward the NH2 terminus of the peptide and Vb at position 27, which is normally a relatively conserved
histidine. This residue may be preferred because of itsis positioned toward the COOH terminus (Garbozi et
al., 1996; Garcia et al., 1996). This structure confirmed small size and/or its ability to form hydrogen bonds with
tryptophan. Second, four of five of the Vb domains thatfunctional studies that had previously proposed a diago-
nal pattern of TCR:MHC class I interaction (Sun et al., have an aspartic acid at position 28 are specifically ex-
panded by the lysine PFR (Vb6, Vb8.1, Vb10, and Vb13).1995). Our data and studies performed by Sant'Angelo
and colleagues (1996) are consistent with these findings A salt bridge may therefore mediate this interaction.
Third, four Vb domains have aromatic amino acids atand suggest that a similar orientation may also apply to
TCR:MHC class II complexes. Further extrapolation position 29. Two of these, Vb2 (W29) and Vb8.1 (Y29),
are expanded by phenylalanine PFRs. A third, Vb16from the TCR:peptide:MHC class I structures suggests
that the Va CDR1 loop would be positioned over the (Y29), may be responsible for the large expansion of T
cells in the group depicted as ªotherº in Figure 6ANH2-terminal PFR, while the Vb CDR1 loop would be
positioned over the COOH-terminal PFR (Garbozi et al., (ªotherº includes the five Vbs for which we do not have
antibodies, i.e., Vb1, Vb15, Vb16, Vb18, and Vb20). De-1996; Garcia et al., 1996). TCR recognition of NH2-termi-
nal PFR was not analyzed in the present study, since it spite these notable correlations, exact determination of
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the structural basis for PFR dependence will require antagonists. In this regard, we have recently shown that
HEL 48±61 can antagonize PFR-dependent hybridomasx-ray crystallography.
Can PFR recognition occur with any immunogenic stimulated with the agonist HEL 48±63 (R. T. C. and
D. A. A. V., unpublished data). These observations differepitope? While our study only analyzed a single epitope,
the data show that different PFRs can mediate depen- from previous studies inwhich key residues were substi-
tuted rather than deleted. Given that naturally processeddence and skew TCR Vb usage. Furthermore, changing
the immunodominant central peptide residue did not peptides can be generated from native HEL with or with-
out the flanking tryptophan residues (Nelson et al., 1992;appear to alter significantly the influence of PFRs. Tak-
ing these data together, we believe that such recognition Vignali et al., 1993), the potential consequence of PFR
recognition on immunoregulation and peptide-basedcan occur with many immunogenic epitopes, unless
self-tolerance suppresses such a response. immunotherapy will need to be determined. Two obser-
vations are relevant to this issue. First, previous studiesThere is increasing interest in developing peptide-
based vaccines to reduce the possibility of inducing have shown that differential processing of antigens may
occur in different APCs or in different intracellular com-autoimmunity against a host protein homologous to the
immunogen or of inducing an inappropriate immune re- partments (Moreno et al., 1991; Parra-Lopez et al., 1997).
Second, recent studies have established that endoge-sponse that may exacerbate rather than alleviate a dis-
ease (reviewed by Berzovsky, 1995; Nardin et al., 1995). nous altered peptide ligands can affect peripheral T cell
responses (Vidal et al., 1996).What are the possible implications of TCR recognition
of PFRs on the immune response and vaccine develop- In summary, we believe that the results from this study
constitute compelling evidence that theTCR can directlyment? The datapresented in this study suggest that TCR
recognition of PFRs may significantly enhance peptide recognize PFRs and that such residues can be as crucial
for TCR recognition as the central peptide residues.immunogenicity. The most important observation was
that T cells from mice immunized with peptides con- Furthermore, recognition of PFRs had a profound effect
on TCR Vb usage that was unique for different PFRs.taining PFRs exhibit a far stronger recall response to
the native HEL protein. This issue is of particular impor- Finally, PFRs appear to significantly enhance peptide
immunogenicity, as was particularly evident from theirtance for vaccine development, since infection with a
pathogen will always result in exposure to the native effect on the recall response to the native HEL protein.
These findings establish the immunological significanceform of the antigen. It is tempting to speculate that
recognition of both NH2- and COOH-terminalPFRs could of PFRs and could have significant implications for im-
munoregulation, vaccine development, and peptide-further potentiate the immune response. While this hy-
pothesis is currently under investigation, our data imply based immunotherapy.
that peptide-based vaccines are likely to be far more
immunogenic with the inclusion of PFRs, assuming that
Experimental Proceduresthe naturally processed antigen also includes such res-
idues.
Generation of Murine T Cell Hybridomas
Peptide elution studies have shown that PFRs are a T cell hybridomas were produced essentially as described (Wood-
unique characteristic of MHC class II±bound peptides land et al., 1993). In brief, B10.BR mice (Jackson Laboratories, Bar
Harbor, ME) were immunized in the base of the tail with 10 nmol of(reviewed by Urban et al.,1993). This feature could result
HEL 48±63 (2 3 50 ml at 100 mM) in complete Freund's adjuvantin the availability of more residues to the TCR on pep-
(Gibco±BRL, Gaithersburg, MD). After 8 days, inguinal and periaortictides bound to MHC class II molecules as compared
lymph nodes were removed into Hank's balanced salt solution andto those bound to MHC class I molecules (Vignali and
single-cell suspensions generated by teasing through 70 mm cell
Strominger, 1994a). Since there appeared to be no dif- strainers (Falcon, Becton Dickinson Labware, Franklin Lakes, NJ).
ference in peptide sensitivity and IL-2 production be- Lymph node cells were depleted of CD81 T cells by panning with
53.6.7, 19.178, and 2.43, and stimulated at 3 3 105/ml with HEL (1tween PFR-dependent and -independent hybridomas,
mM; Sigma, St. Louis, MO), irradiated splenocytes (106/ml), and rIL-2it is possible that PFR-recognition may allow an MHC
(10 U/ml; Genzyme, Cambridge, MA) in complete S-MEM (Gibco±class II±restricted response to develop a more diverse
BRL) with 10% fetal calf serum (FCS) (Atlanta Biologicals, Norcross,T cell repertoire. Indeed, immunization with peptides
GA, or HyClone, Logan, UT) (complete S-MEM: 2 mM glutamine, 1
containing PFRs gave rise to T cells expressing unique mM pyruvate, 100 mM nonessential amino acids, 5 mM HEPES,
TCR Vb elements. While this is consistent with the idea 5.5 3 1025 M 2-mercaptoethanol, 100 U/ml penicillin, 100 mg/ml
that TCR recognition of PFRs increases the size of the streptomycin; all from Gibco±BRL). After 3 days viable cells were
separated over Lymphocyte Separation Medium (Organon Teknika,precursor T cell population, formal limiting dilution anal-
Durham, NC) and cultured overnight (105/ml) with 10 U/ml rIL-2. Theysis will be required to resolve this issue. Furthermore,
following day, cells were fused with the T cell thymoma BW-TCRab2this underlying distinction between MHC class I and
using PEG-1500, washed, and cloned by limiting dilution into 96-well
class II±restricted responses clearly warrants further in- microtiter plates. After 24 hr, hypoxanthine±aminopterin±thymidine
vestigation. (HAT) (Gibco±BRL) selection media was added to select for BW:T
A number of studies have shown that substitution of cell hybridomas. Cells were expanded into 24-well plates under HAT
selection and then into flasks with media containing hypoxanthine±key TCR contact residues can give rise to peptides that
thymidine. A second fusion was performed using lymph node T cellsantagonize (inhibit) the response to agonist (stimulatory)
from HEL 48±61KK±immunized mice as described above exceptpeptides (Smilek et al., 1991; De Magistris et al., 1992;
that HEL 48±61KK and irradiated dendritic cells (3 3 104/ml) were
Evavold et al., 1993; Jameson et al., 1993). Given the used for the restimulation in vitro. Preliminary screening involved
striking dependence on PFRs exhibited by the T cells analysis of CD3 and CD4 expression by flow cytometry and of IL-2
analyzed in our study, it is intriguing to question whether production in response to the immunogen and HEL where appro-
priate. Hybridomas that were less than 90% CD31CD41 were clonedpeptides lacking these residues could act as peptide
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by fluorescence-activated cell sorting (FACS) as previously de- MA), and cloned into pAlter (Promega, Madison, WI) for sequence
verification.scribed (Vignali and Strominger, 1994b; Vignali et al., 1996) or en-
riched by panning with anti-CD4 (GK1.5). Third, the HEL 48±61AA:H-2Ak and HEL 48-L56A-63:H-2Ak mu-
tants were made using the Altered Sites mutagenesis kit essentially
as described by the manufacturer (Promega). The construct pro-
Antigen Presentation Assays duced in the previous step was used as the template for ssDNA.
Assays were performed essentially as described elsewhere (Vignali The following primers were used: W62A:W63A, 59 CAG ATC AAC
and Strominger, 1994b; Vignali et al., 1996). In brief, T cell hybrido- AGC CGC GCA GCT GGA GGT GGA GGC 39; and L56A, 59 GAC
mas (5 3 104/well) were stimulated with LK35.2 or CH12.1.16 cells TAC GGA ATC GCT CAG ATT AAT AGC CGC TGG TGG 39. All three
(2.5 3 104/well) as APCs and pulsed with synthetic peptides (Center HEL:H-2Akb mutants were then cloned into the expression vector
for Biotechnology [CBT] core facility at St. Jude Children's Research pHbApr-IIpuro (Vignali et al., 1996) and cotransfected with the wild-
Hospital [SJCRH] or Chiron Technologies [Mimotopes], Raleigh, NC) type H-2Aka chain (kindly provided by R. N. Germain, National Insti-
or with HEL (Sigma). Peptides were purified by reverse-phase high- tutes of Health) in pHbApr-Ineo into the A20.J B cell line (H-2Ed,
pressure liquid chromatography (Vidac C-18, The Nest Group, H-2Ad) as previously described (Vignali et al., 1992).
Southborough, MA), verified by mass spectrometry, and quantified
by amino acid analysis (Chiron Technologies or Harvard Microchem-
Flow Cytometry
istry Unit, Harvard University, Cambridge, MA). Supernatants (50 ml)
Analysis of T cell hybridomas for CD3 and CD4 expression was
were removed after 24 hr for estimation of IL-2 secretion by culturing
performed as described elsewhere (antibodies from Pharmingen,
with the IL-2±dependent T cell line CTLL-2. Two types of assay were San Diego, CA) (Vignali and Strominger, 1994b; Vignali et al., 1996).
performed. In one, absolute IL-2 concentrations were quantified by
TCR Vb gene usage was initially determined by flow cytometry using
titrating culture supernatants against a recombinant murine IL-2
a panel of monoclonal antibodies (details in Tomonari et al., 1989;
standard (Genzyme) in 50 ml of medium and culturing with 104
Deckhut et al., 1993; Cole et al., 1994; Daly et al., 1995). Antibodies
CTLL-2 cells (50 ml) for 24 hr. Proliferation was determinedby adding
used were KT50 (anti-Va8 [subset]), KT65 (anti-Va8 [subset]), RR8.1
20 ml of Alamar Blue (Alamar Biosciences, Sacramento, CA) diluted
(anti-Va11 [subset]), B20.6 (anti-Vb2), KJ25 (anti-Vb3), KT-4 (anti-
1:2 in medium, incubating overnight, and measuring absorbance at
Vb4), MR9±4 (anti-Vb5.1,5.2), MR9±8 (anti-Vb5.1), RR4±7 (anti-Vb6),
570 nm with a 595 nm reference. In the other assay, the concentra-
TR130 (anti-Vb7), F23.1 (anti-Vb8.1,8.2,8.3), F23.2 (anti-Vb8.2), KJ16
tion of peptide (EC50) required to stimulate a 50% maximal CTLL (anti-Vb8.1,8.2), MR5±2 (anti-Vb8.2,8.3), Vb8.3 (anti-Vb8.3), MR10.2
response was determined by culturing 100 ml of supernatant with
(anti-Vb9), KT-106 (anti-Vb10), RR3±15 (anti-Vb11), Vb12 (anti-Vb12),
104 CTLL-2 cells (100 ml) for 24 hr. Proliferation was determined by
MR12±5 (anti-Vb13), and 14±2 (anti-Vb14) (antibodies kindly pro-
pulsing with [3H]thymidine (1 mCi/well) (Du Pont, Wilmington, DE)
vided by M. Blackman, Immunology, SJCRH).
for the final 6 hr of culture.
Reverse Transcription±PCR Analysis
and Sequence DeterminationCAP Transfectants
APCs expressing H-2Ak molecules containing a single CAP were Total RNA (z10 mg) was prepared from 106 T cells using STAT-60
(TEL-TEST, Friendswood, TX). To produce cDNA, 2 mg of RNA andproduced essentially as described by Kozono and colleagues (1994).
Three CAP constructs were produced by attaching the appropriate 0.2 mgof oligo dT (Promega) in 10 ml of diethyl pyrocarbonate (0.1%)±
H2O was heated to 908C for 2 min, cooled slowly to 508C, and placedHEL peptide sequence to the 59 end of the H-2Akb chain using
recombinant PCR. They are referred to as HEL.48±63.CAP, HEL.48± in ice. RNA was reverse transcribed at 428C for 60 min in the pres-
ence of 1.2 ml of SuperScript II RT (Gibro±BRL), 4 ml of Superscript61AA.CAP, and HEL.48-L56A-63.CAP. These were constructed in
three stages. II RT buffer, 2 ml of DTT, 2 ml of dNTP (10 mM), and 0.8 ml of RNasin
(Promega). The cDNA was heated to 708C for 5 min and H2O addedFirst, three fragments containing overlapping sequences were
created: (1) H-2Akb signal peptide and the first three residues of the to 100 ml. PCR reactions were performed by using 5 ml of cDNA, 2
ml of dNTP (10 mM), 25 pmol of each primer, Taq buffer, and 4 Umature protein, produced by PCR using an H-2Akb chain cDNA as
template (kindly provided by R. N. Germain, National Institutes of of Taq DNA polymerase (Perkin-Elmer, Branchburg, NJ). The PCR
primers were optimized using VectorNTI (InforMax, Gaithersburg,Health, Bethesda, MD): DV59e forward primer, Asp718±59 CCC GGT
ACC ATG GCT CTG CAG ATC CCC AGC 39, and DV59b reverse MD), as follows. Forward primers: Va1Ð59 GCA GCA GAG CCC
AGA ATC CCT C 39; Va2Ð59 GCA GGT GAG ACA AAG TCC CCAprimer, 59 TCC GTA GTC GGT ACT CCC ATC GGA GTT TCC GCC
CTC AGT 39; (2) HEL 48±63 plus the linker originally described (Ko- ATC T 39; Va3Ð59 GGA GAC CCA GTG GTT CAA GGA GTG A 39;
Va4AÐ59 GAA GCA GCA GAG GTT TTG AAG CTA CAT A 39 orzono et al., 1994) (DGSTDYGILQINSRWWGGGGSLVPRGSGGGGS)
generated by annealing two oligonucleotides: DV53a, 59 GAT CGA Va4BÐ59 CAG CAG AGG GTT TGA AGC CAC ATA 39; Va5Ð59 GTG
GAG CAG CGC CCT CCT C 39; Va6Ð59 TGT AGC CAC GCC ACATGG GAG TAC CGA CTA CGG AAT CCT ACA GAT CAA CAG CCG
CTG GTG GGG AGG TGG AGG CTC ACT AGT GCC CCG AGG CTC ATC AGT GG 39; Va7Ð59 GCC GAG AAA GTG ATT CAG GTC TGG
39; Va8Ð59 GGA GCT TCA CAG ACA ACA AGA GGA CC 39 orTGG AGG TGG AGG CTC C 39, and DV53b, 59 CAT GGG AGC CTC
CAC CTC CAG AGC CTC GGG GCA CTA GTG AGC CTC CAC CTC Va8SÐ59 CCT GTG AAG CTG AAC TGC ACC TAT CAG 39; Va9Ð59
GAG CCT CCA GTT TCT CCT CAA ATA CAT C 39; Va10Ð59 AGTCCC ACC AGC GGC TGT TGA TCT GTA GGA TTC CGT AGT CGG
TAC TCC CAT C 39. This was used as a template for PCR: DV59a CCC GCG TCC TTG GTT CTG 39; Va11 Ð59 TCA GGA ACA AAG
GAG AAT GGG AGG 39; Va12Ð59 TGG TAC CGA CAG GTT CCCforward primer, 59 ACT GAG GGC GGA AAC TCC GAT GGG AGT
ACC GAC TAC GGA 39; and DV59d reverse primer, 59 GGA GGT CAC C 39; Va13Ð59 GCA GGT GGA GCA GCT TCC TTC C 39;
Va14Ð59 GGC AAA GGT CTT GTG TCC CTG ACA G 39; Va15Ð59GGA GGC TCC GAA AGG CAT TTC GTG CAC 39; (3) H-2Akb chain
from residue 4 to the stop codon, produced by PCR using an H-2Akb GGA GAG AAG GTC GAG CAA CAC GAG 39; Va16Ð59 GAA CTT
GGT GAG TGG TCA AGC AAA CAC 39; Va17Ð59 GTG ACA ATGchain cDNA as template: DV59c forward primer, 59 TCT GGA GGT
GGA GGC TCC GAA AGG CAT TTC GTG CAC TCT 39, and DV59f GAC TGT GTG TAT GAA ACC C 39; Va18Ð59 TCA GAG CCA CCC
TTG ACA CCT CC 39; Va19Ð59 ATT TCT CCA CTT TCC TGA GCCreverse primer, BamHI±59 CGC GGA TCC TCA CTG CAG GAG CCC
TGC TGG 39. PCR conditions were as follows: 958C for 60 s, for 1 GC 39; and Va20 Ð59 TGC CTG GTA CAA AAA ATA CCC TGA CAA
C 39. Reverse primers: Ja26Ð59 GTG CCA AGA CCG AAG GTT AATcycle; 948C for 30 s, 458C for 60 s, and 728C for 90 s, for 2 cycles;
948C for 30 s, 508C for 30 s, and 728C for 90 s, for 30 cycles; and CCC 39; CaAÐ59 GTC GGT GAA CAG GCA GAG GGT G 39 (melting
temperature 59.2±61.8; Va sequences can be found in Arden et al.,728C for 3 min, for 1 cycle. PCR products were gel purified.
Second, recombinant PCR was performed in two steps using an 1995). All oligonucleotides were synthesized by the CBT facility at
SJCRH. The following conditions were used for the PCR: 958C forequimolar amount of each fragment as the template. Fragments 1
and 2 were joined using DV59e and DV59d, and then this product 60 s, for 1 cycle; 948C for 30 s, 508C for 30 s, 728C for 60 s, for 35
cycles; and 728C for 3 min, for 1 cycle.was added to fragment 3 and the construct completed using DV59e
and DV59f as primers. The PCR product was then cut with Asp718 The TCR Va subfamily and VDJ junction were determined by se-
quence analysis. PCR fragments were cloned into pCR2.1 using(Boehringer Mannheim, Indianapolis, IN) and BamHI (NEB, Beverly,
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the TA cloning kit (Invitrogen, Carlsbad, CA). DNA sequencing was The percentage of reactivated cells expressing specific Vb ele-
ments as shown in Figure 6A was then determined using the follow-performed by the CBT at SJCRH using PE-ABD PRISM dye primer
chemistry and a PE-ABD PRISM 377 automated DNA sequencer. ing equation:
Sequence alignment and verification was performed using the GCG
Wisconsin Package V8.1 (Genetics Computer Group, Madison WI)
running on a DEC Alpha Server 8200. 1
CD41.CD251.Vb1(reactiv)
Total CD41(reactiv)
2
CD41.CD251.Vb1(unactiv)
Total CD41(unactiv) 2
1CD4
1.CD251(reactiv)
Total CD41(reactiv)
2
CD41.CD251(unactiv)
Total CD41(unactiv) 2
3 100
TCR Vb usage of hybridomas that werenegative by flow cytometry
was determined by reverse transcription±PCR. The Vb1, Vb15, Vb16,
Vb18, and Vb20 primers and protocol are described elsewhere (Cole
Data presented in Figure 6B, in which T cells were reactivatedet al., 1994).
with either the immunogen or HEL-48±61, were determined using
the following equation:T Cell Proliferation Assay
B10.BR mice (Jackson Laboratories) were immunized with 10 nmol
of either HEL, HEL 48±63, or HEL 48±61 as described above (see
Generation of Murine T Cell Hybridomas). After 10 days, lymph node
1CD4
1.CD251.Vb1(peptide2reactiv)
Total CD41(peptide2reactiv)
2
CD41.CD251.Vb1(unactiv)
Total CD41(unactiv) 2
1CD4
1.CD251(immunogen2reactiv)
Total CD41(immunogen2reactiv)
2
CD41.CD251(unactiv)
Total CD41(unactiv) 2
3 100
cells (5 3 105/well) were removed and cultured in 96-well flat-bottom
plates in complete S-MEM with 5% FCS for 3 days. Lymph node
cells from individual mice were stimulated with HEL peptides or
where immunogen-reactiv 5 T cells reactivated with the immuno-protein and proliferation measured by pulsing with [3H]thymidine (1
gen, and peptide-reactiv 5 T cells reactivated with either the immu-mCi/well; Du Pont, Wilmington, DE) for the final 12 hr of culture.
nogen or HEL-48±61.
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